Evidence map›Paper›PMID 42387193›Full record

ArticleMikrochimica acta2026

Triple-amplification electrochemiluminescence aptasensor integrating single-atom nanozyme catalysis with CRISPR-Cas12a/HCR cascade for zearalenone detection.

Huifeng Xu, Xiao Hu, Ronglin Chen, Shufei Huang, Lili Wang, Lishuang Yu, Xihai Li, Xi Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Huifeng XuAcademy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, P. R. China. xuhf@fjtcm.edu.cn.
Xiao HuCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, Fujian, P.R. China.
Ronglin ChenAcademy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, P. R. China.
Shufei HuangAcademy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, P. R. China.
Lili WangAcademy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, P. R. China.
Lishuang YuCollege of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, Fujian, P.R. China.
Xihai LiAcademy of Integrative Medicine, College of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, P. R. China. lixihaifz@163.com.
Xi ZhuCollege of Life Sciences, Fujian Agriculture and Forestry University, Fuzhou, Fujian, P.R. China. zhuxi@fafu.edu.cn.

Funding

Natural Sciences Foundation of Fujian Province 2023J01152NSFC 81773894
6 · The paper itself

Abstract

Single-atom nanozymes (SANs) are emerging as interfacial catalysts that can modulate surface-confined reactive oxygen species (ROS) generation at the electrode/solution boundary. Herein, an interface-driven electrochemiluminescence (ECL) aptasensor was constructed for the ultrasensitive detection of zearalenone (ZEN), a mycotoxin of significant concern. Oxidase-mimetic Co-N/C SANs (Co-SAC@NC) immobilized on a glassy carbon electrode catalyze the reduction of dissolved O

Indexed as

Aptamers, NucleotideBiosensing TechniquesCRISPR-Cas SystemsElectrochemical TechniquesZearalenoneCatalysisDNAElectrodesFerrous CompoundsLimit of DetectionLuminescent MeasurementsMetallocenesAptamers, NucleotideDNAFerrous CompoundsMetallocenesZearalenoneAptasensorCRISPR-Cas12aElectrochemiluminescenceHybridization chain reactionSingle-atom nanozymesZearalenone

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.